Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway

H Nakanishi1, C Taccioli1, J Palatini1

  • 1Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA.

Oncogene
|February 19, 2013
PubMed

Insights

Loss of miR-125b-1, a microRNA, is linked to head and neck squamous cell carcinomas (HNSCC). This microRNA regulates TACSTD2, impacting cancer progression and potentially serving as a biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are implicated in cancer, but their specific roles in head and neck squamous cell carcinomas (HNSCC) require further elucidation.
  • Understanding miRNA involvement is crucial for identifying novel therapeutic targets and diagnostic markers in HNSCC.

Purpose of the Study:

  • To investigate the contribution of specific miRNAs and their target messenger RNAs (mRNAs) to the pathogenesis and progression of HNSCC.
  • To identify and characterize the role of miR-125b in HNSCC development.

Main Methods:

  • miRNA profiling of HNSCC cell lines, normal head and neck tissues, and normal keratinocytes to identify differentially expressed miRNAs.
  • Analysis of miR-125b-1 expression, promoter methylation, and identification of its direct mRNA targets, including TACSTD2.
  • Investigation of the functional impact of miR-125b-1 on the mitogen-activated protein kinase (MAPK) pathway via TACSTD2 regulation.

Main Results:

  • A subset of differentially expressed miRNAs, including miR-125b, was identified in HNSCC.
  • Decreased expression of miR-125b-1 and hypermethylation of its promoter were observed in HNSCC compared to non-malignant tissues.
  • TACSTD2 was validated as a direct target of miR-125b-1, and its dysregulation was linked to MAPK pathway dysfunction.

Conclusions:

  • Loss of miR-125b-1 expression, potentially due to promoter hypermethylation, plays a significant role in the pathogenesis and progression of HNSCC.
  • The miR-125b-1/TACSTD2 axis influences MAPK pathway activity, suggesting a potential therapeutic target.
  • Dysregulation of miR-125b-1 may contribute to the development of other epithelial cancers as well.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...